PTHS · NYSE
Companies at this level ended the following year delisted, bankrupt, restated or silent 13.1% of the time, against 4.0% for companies with a clean record.
Hover or tap a dot to see the filings behind that score.
Chromocell Therapeutics Corporation (the “Company”) is unable to complete the preparation, review and filing of its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”) by April 1, 2024 without unreasonable effort or expense because the Company requires additional time (i) to compile and analyze supporting documentation and to prepare and review its financial statements in order to complete the Form 10-K in order to permit the Company’s independent registered public accounting firm to complete its audit of the condensed financial statements included in the Form 10-K and (ii) to ensure adequate disclosure of the financial information required to be included in the Form 10-K as a result of the Company’s recent initial public offering, which have required additional time and review to ensure accurate reporting
NT 10-K, filed 2024-04-01 · auditor
2026-08-13accounts declared unreliable SEC →
2026-05-21auditor changed or resigned SEC →
2025-04-17auditor changed or resigned SEC →
Chromocell Therapeutics Corporation (the “Company”) is unable to complete the preparation, review and filing of its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”) by April 1, 2024 without unreasonable effort or expense because the Company requires additional time (i) to compile and analyze supporting documentation and to prepare and review its financial statements in order to complete the Form 10-K in order to permit the Company’s independent registered public accounting firm to complete its audit of the condensed financial statements included in the Form 10-K and (ii) to ensure adequate disclosure of the financial information required to be included in the Form 10-K as a result of the Company’s recent initial public offering, which have required additional time and review to ensure accurate reporting
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice